These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14141371)

  • 1. [THERAPY OF PULMONARY TUBERCULOSIS BY THE ADMINISTRATION OF HIGH DOSES OF INH].
    DELOFF L; GRZESKOWSKI J; MICHALIK M; OKLEK K
    Z Tuberk Erkr Thoraxorg; 1964 Jan; 121():58-61. PubMed ID: 14141371
    [No Abstract]   [Full Text] [Related]  

  • 2. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [STUDIES ON COMBINED INH-ETHIONAMIDE TREATMENT OF PULMONARY TUBERCULOSIS WITH LOW ETHIONAMIDE DOSAGE].
    DISSMANN E; IGLAUER E; ZECHNER E
    Tuberkulosearzt; 1963 Nov; 17():696-704. PubMed ID: 14098678
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE LEVEL OF FREE INH IN THE BLOOD SERUM DURING ITS SIMULTANEOUS ADMINISTRATION WITH 5-BROMOSALICYLOHYDROXAMIC ACID (T4O)].
    TUSZYNSKA B; ZAJACZKOWSKA J; KRAKOWKA P
    Gruzlica (1926); 1964 Feb; 32():149-54. PubMed ID: 14136688
    [No Abstract]   [Full Text] [Related]  

  • 5. SERUM IRON, COPPER, IRON-BINDING CAPACITY AND MARROW HEMOSIDERIN IN PULMONARY TUBERCULOSIS.
    TANI P
    Ann Med Intern Fenn; 1965; 54():SUPPL 44:1-61. PubMed ID: 14346381
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL VALUE OF THE DETERMINATION OF THE ACTIVE INH LEVEL BY THE VERTICAL DIFFUSION METHOD IN TUBERCULOUS PATIENTS].
    Gruzlica (1926); 1963 Oct; 31():1021-7. PubMed ID: 14092755
    [No Abstract]   [Full Text] [Related]  

  • 7. The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.
    Donald PR; Sirgel FA; Botha FJ; Seifart HI; Parkin DP; Vandenplas ML; Van de Wal BW; Maritz JS; Mitchison DA
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):895-900. PubMed ID: 9310010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct Detection of Rifampin and Isoniazid Resistance in Sputum Samples from Tuberculosis Patients by High-Resolution Melt Curve Analysis.
    Anthwal D; Gupta RK; Bhalla M; Bhatnagar S; Tyagi JS; Haldar S
    J Clin Microbiol; 2017 Jun; 55(6):1755-1766. PubMed ID: 28330890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood levels of isoniazid in Indian children with tuberculosis.
    Rangari GM; Roy V; Sethi GR; Mishra TK; Khanna A
    Indian J Tuberc; 2015 Apr; 62(2):80-5. PubMed ID: 26117476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative results of INH therapy in large doses and routine doses in 160 cases of pulmonary tuberculosis].
    LEVI-VALENSI A; AUGUSTI G; LEVI-VALENSI P; KESPI JM
    Rev Prat; 1963 Jan; 13():323-9. PubMed ID: 13930093
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of mycobacterial populations found in the sputum of tuberculous patients after prolonged isoniazid therapy.
    PEIZER LR; CHAVES AD; WIDELOCK D
    Am Rev Respir Dis; 1960 Oct; 82():568-73. PubMed ID: 13733935
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of Pulmonary Tuberculosis and Detection of Resistance to Rifampin and Isoniazid through Direct Molecular Methods in Stool Samples.
    Yousef SA; AbdelRahim KA; Ahmed AO; Almaary KS; Mohamed AM
    Ann Clin Lab Sci; 2016 Dec; 46(6):616-621. PubMed ID: 27993874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of INH (Isoniazid) inhalation in patients with endobronchial tuberculosis (EBTB)].
    Yokota S; Miki K
    Kekkaku; 1999 Dec; 74(12):873-7. PubMed ID: 10655693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SINGLE DAILY DOSE REGIMEN OF ISONIAZID AND PAS IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    WILSON JL; LAMPE WT
    Am Rev Respir Dis; 1964 May; 89():756-9. PubMed ID: 14145228
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of isoniazid inhalation in patients with endobronchial tuberculosis].
    Miki K; Yokota S; Hiraga T; Yamaguchi T; Nakagawa M; Maekura R; Ito M; Ogura T
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):31-5. PubMed ID: 10087873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
    Mah A; Kharrat H; Ahmed R; Gao Z; Der E; Hansen E; Long R; Kunimoto D; Cooper R
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):210-5. PubMed ID: 25574921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.